| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |